{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:23:52Z","timestamp":1788521032852,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ejogrb.2014.01.019","type":"journal-article","created":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T04:46:12Z","timestamp":1390106772000},"page":"124-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Association between labetalol use for hypertension in pregnancy and adverse infant outcomes"],"prefix":"10.1016","volume":"175","author":[{"given":"Ri-hua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Krewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Mattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Nerenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Wu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.01.019_bib0005","first-page":"1","article-title":"Hypertension and pregnancy guidelines","volume":"30","author":"SOGC","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/oxfordjournals.epirev.a017954","article-title":"Epidemiology of pregnancy-induced hypertension","volume":"19","author":"Zhang","year":"1997","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0015","first-page":"37","article-title":"Maternal mortality in British Columbia in 1971-86","volume":"139","author":"Wittmann","year":"1988","journal-title":"CMAJ"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0020","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/0002-9378(90)90653-O","article-title":"Report on high blood pressure in pregnancy","volume":"163","author":"National High Blood Pressure Education Working Group","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2125.2011.04002.x","article-title":"How to manage hypertension in pregnancy effectively","volume":"72","author":"Magee","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.106.075895","article-title":"Update on the use of antihypertensive drugs in pregnancy","volume":"51","author":"Podymow","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0035","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"1","author":"Abalos","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0040","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/AOG.0b013e318249ff06","article-title":"Chronic hypertension in pregnancy","volume":"119","author":"ACOG Practice Bulletin","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0045","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, and Treatment of high blood pressure. The Seventh Report of the Joint Committee","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.ejogrb.2014.01.019_bib0050","first-page":"S1","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"JOGC"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0055","first-page":"CD002863","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","volume":"3","author":"Magee","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0020-7292(95)02351-C","article-title":"Labetalol vs. methydopa in the treatment of pregnancy-induced hypertension","volume":"49","author":"El-Qarmalawi","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ejogrb.2014.01.019_bib0070","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference of birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/00016348409157129","article-title":"The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats","volume":"118","author":"Karlsson","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00016348409157128","article-title":"Maternal beta-adrenoceptor blockade reduces fetal tolerance to asphyxia. A study in pregnant sheep","volume":"118","author":"Kjellmer","year":"1984","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1515\/JPM.2004.058","article-title":"Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance","volume":"32","author":"Houlihan","year":"2004","journal-title":"J Perinat Med"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0090","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00404-011-2205-2","article-title":"Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa","volume":"285","author":"Molvi","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0095","first-page":"297","article-title":"Hypoglycaemia secondary to labetalol infusion","volume":"21","author":"Immanni","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.earlhumdev.2011.12.012","article-title":"Neonatal side effects of maternal labetalol treatment in severe preeclampsia","volume":"88","author":"Heida","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0105","series-title":"Pharmacoepidemiology","first-page":"217","article-title":"Health databases in Saskatchewan","year":"1994"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0110","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0895-4356(99)00237-1","article-title":"Assessing the Saskatchewan database for outcomes research studies of depression and its treatment","volume":"53","author":"West","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1096-9926(199907)60:1<33::AID-TERA9>3.0.CO;2-X","article-title":"Improvement of drug exposure data in a registration of congenital anomalies. Pilot study: pharmacist and mother as sources for drug exposure data during pregnancy","volume":"60","author":"De Jong van den Berg","year":"1999","journal-title":"Teratology"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0120","series-title":"Modern epidemiology","author":"Rothman","year":"1998"},{"key":"10.1016\/j.ejogrb.2014.01.019_bib0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejogrb.2013.09.032","article-title":"Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population","volume":"171","author":"Xie","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:30:31Z","timestamp":1759555831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":25,"alternative-id":["S0301211514000451"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.01.019","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between labetalol use for hypertension in pregnancy and adverse infant outcomes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}